Bank Julius Baer & Co
ABBV icon

Bank Julius Baer & Co’s AbbVie ABBV Stock Holding History

Bank Julius Baer & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$27.1M Buy
124,985
+34,128
+38% +$7.57M 0.08% 130
2025
Q4 		$20.8M Buy
90,857
+10,447
+13% +$2.38M 0.06% 147
2025
Q3 		$18.6M Buy
80,410
+26,627
+50% +$5.42M 0.05% 158
2025
Q2 		$9.98M Buy
53,783
+1,751
+3% +$325K 0.03% 187
2025
Q1 		$10.8M Buy
52,032
+4,451
+9% +$865K 0.04% 185
2024
Q4 		$8.95M Buy
47,581
+4,790
+11% +$881K 0.03% 211
2024
Q3 		$9.35M Buy
42,791
+6,399
+18% +$1.19M 0.03% 193
2024
Q2 		$6.83M Sell
36,392
-10,990
-23% -$1.82M 0.03% 173
2024
Q1 		$8.55M Buy
47,382
+5,639
+14% +$972K 0.03% 174
2023
Q4 		$6.47M Buy
41,743
+12,361
+42% +$1.8M 0.03% 193
2023
Q3 		$4.38M Buy
29,382
+1,299
+5% +$191K 0.03% 183
2023
Q2 		$3.78M Sell
28,083
-4,833
-15% -$709K 0.02% 189
2023
Q1 		$5.25M Buy
32,916
+1,011
+3% +$155K 0.03% 181
2022
Q4 		$5.16M Sell
31,905
-39
-0.1% -$5.98K 0.04% 181
2022
Q3 		$4.29M Buy
31,944
+1,766
+6% +$253K 0.03% 170
2022
Q2 		$4.62M Buy
30,178
+1,734
+6% +$265K 0.03% 173
2022
Q1 		$4.61M Sell
28,444
-6,982
-20% -$1.01M 0.03% 176
2021
Q4 		$4.8M Buy
35,426
+2,070
+6% +$245K 0.03% 205
2021
Q3 		$3.6M Buy
33,356
+17,323
+108% +$1.98M 0.02% 212
2021
Q2 		$1.81M Buy
16,033
+1,897
+13% +$214K 0.01% 294
2021
Q1 		$1.53M Buy
14,136
+16
+0.1% +$1.71K 0.01% 291
2020
Q4 		$1.51M Buy
14,120
+5,174
+58% +$497K 0.01% 290
2020
Q3 		$784K Buy
8,946
+413
+5% +$38.9K 0.01% 322
2020
Q2 		$836K Buy
8,533
+1,377
+19% +$121K 0.01% 296
2020
Q1 		$545K Buy
+7,156
New +$610K 0.01% 303

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank Julius Baer & Co's ABBV Position: Q1 2026 in Review

Bank Julius Baer & Co increased its AbbVie (ABBV) stake by 38% in Q1 2026, buying an estimated $7.57M and bringing the position to 124,985 shares worth $27.1M. The position accounts for 0.08% of the portfolio, ranked #130.

Bank Julius Baer & Co first reported a position in ABBV in Q1 2020 and has held it in 25 quarters since. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Bank Julius Baer & Co held 124,985 shares of AbbVie worth $27.1M as of Q1 2026.
  • Bank Julius Baer & Co bought 34,128 AbbVie shares in Q1 2026, an estimated $7.57M.
  • AbbVie made up 0.08% of Bank Julius Baer & Co's portfolio in Q1 2026, its #130 holding.
  • Bank Julius Baer & Co first reported a position in AbbVie in Q1 2020 and has held it in 25 quarters since.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Bank Julius Baer & Co's 13F filing for Q1 2026, filed 5 May 2026.